Clene Nanomedicine
Synthia Larson possesses extensive experience in regulatory affairs and project management within the pharmaceutical industry. Currently serving as the Director of Regulatory Affairs and Project Management at Clene Nanomedicine, Synthia has previously held key positions, including Director of CMC R&D Technical Services at Teva Pharmaceuticals, Associate Director of Analytical R&D at Actavis plc (now Allergan), and Sr. Manager of Technical Services at Watson Pharmaceuticals (New Jersey) Inc. Additionally, Synthia has contributed expertise as a Quality Assurance Consultant at Pharmaceutical Systems, Inc.
This person is not in any teams
This person is not in any offices
Clene Nanomedicine
Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases.